知镜 Cognispect · 医学文献与研究工作台

Diagnostic Accuracy of Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Differentiating Tumor and Bland Thrombus in Patients With Cancer: A Systematic Review and Meta-Analysis.

Eltaher B, Mahmoud A, Balusu K, Manshahia PS, Abdelhay A, Reghis M, Ng S, Afzal A, Sanfilippo K, Patell R.
European journal of haematology · 2026-08-28 · PMID 42661593

文献摘要

Introduction Differentiating tumor thrombus from bland thrombus can be challenging. This study assessed the diagnostic performance of positron emission tomography-computed tomography (PET/CT) scans in differentiating bland versus tumor thrombi in patients with cancer. Methods We systematically searched for observational studies evaluating the diagnostic accuracy of PET/CT scans in differentiating tumor from bland thrombi in adult cancer patients. We included patients with suspected tumor or bland thrombus on PET/CT who underwent histopathological evaluation and/or confirmatory imaging or clinical follow-up. Sensitivity and specificity were estimated using a random-effects model. Positive and negative likelihood ratios (LR+ and LR-) and diagnostic odds ratio (DOR) were derived from the pooled estimates. Results Five studies were included (217 patients; mean age 55.9 years). Hepatobiliary malignancies (49%) and renal tumors (24%) were the most frequent, with the renal vein, portal vein, and inferior vena cava most frequently involved. Maximum standardized uptake value (SUVmax) was significantly higher in malignant compared to bland thrombi, with reported diagnostic cutoffs ranging from 2.25 to 3.63. PET/CT scan showed diagnostic accuracy with pooled sensitivity 92.2%, specificity 94.2%, LR- 0.121, LR+ 10.919, and DOR of 91.770. Conclusion PET/CT scan may be beneficial in distinguishing tumor from bland thrombus in cancer patients.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。